XTL Biopharmaceuticals Ltd. (TLV:XTLB)
4.600
+0.100 (2.22%)
Apr 1, 2025, 3:58 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 40.54 million as of April 1, 2025. Its market cap has increased by 118.84% in one year.
Market Cap
40.54M
Enterprise Value
34.15M
Revenue
171.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.60
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 40.54M, a decrease of -94.97%. That is a compound annual growth rate of -14.15%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 65.20B |
Danel (Adir Yeoshua) | 2.12B |
Kamada | 1.47B |
Bait Bakfar | 897.25M |
Novolog (Pharm-Up 1966) | 845.24M |
Ilex Medical | 741.81M |
BrainsWay | 657.44M |
SofWave Medical | 555.35M |